EU watchdog approves P&G, Teva joint venture, Reuters reports

The European Commission has approved the proposed joint venture by Procter & Gamble (PG) and Teva (TEVA) to sell over-the-counter medicines, Reuters reports. The companies are targeting $1.3B in annual sales from the venture and see the potential to grow to $4B in annual sales towards the end of the decade.

View Comments (0)